Skip to main content
Erschienen in: Digestive Diseases and Sciences 8/2008

01.08.2008 | Original Paper

The Expression and Clinical Significance of DNA Methyltransferase Proteins in Human Gastric Cancer

verfasst von: Wen-Jin Ding, Jing-Yuan Fang, Xiao-Yu Chen, Yan-Shen Peng

Erschienen in: Digestive Diseases and Sciences | Ausgabe 8/2008

Einloggen, um Zugang zu erhalten

Abstract

This study investigates the varied expression of DNA methyltransferase (DNMT) proteins in gastric cancer (GC) and their relationship with the biological behavior of the tissues. Immunohistochemistry was used to detect the expression of the 3 DNMTs in gastric tissues. We discovered that the positive rates of DNMT1, DNMT3a, and DNMT3b expression in GC tissues were 81.6%, 81.6%, and 68.4%, respectively, and they were significantly higher than those of both para-cancerous (39.5%, 50%, and 44.7%) and normal tissues (10.5%, 10.5%, and 7.9%). DNMT1 was well distributed in the cytoplasm and nuclei of tumor cells or glands, while DNMT3a and 3b were well distributed only in the cytoplasm, as shown by staining a dark brown color. A significant correlation between the DNMT1 and DNMT3a proteins (P < 0.01), a low correlation between DNMT3a and DNMT3b (P < 0.05), and no correlation between DNMT1 and DNMT3b (P > 0.05) were observed. DNMT1 protein expression exhibited no correlation with age, lymphnode metastasis, and also tumor differentiation, but it may have had a correlation with gender. The DNMT3 family was not associated with these factors. Therefore, DNMT overexpression is involved in gastric tumorigenesis, but there is no correlation between the DNMTs and the biological behaviors of tissues.
Literatur
1.
Zurück zum Zitat He QY, Cheung YH, Leung SY, Yuen ST, Chu KM, Chiu JF (2004) Diverse proteomic alterations in gastric adenocarcinoma. Proteomics 4:3276–3287PubMedCrossRef He QY, Cheung YH, Leung SY, Yuen ST, Chu KM, Chiu JF (2004) Diverse proteomic alterations in gastric adenocarcinoma. Proteomics 4:3276–3287PubMedCrossRef
2.
Zurück zum Zitat Yoshihara T, Kadota Y, Yoshimura Y, Tatano Y, Takeuchi N, Okitsu H, Umemoto A, Yamauchi T, Itoh K (2006) Proteomic alteration in gastric adenocarcinomas from Japanese patients. Mol Cancer 25(5):75CrossRef Yoshihara T, Kadota Y, Yoshimura Y, Tatano Y, Takeuchi N, Okitsu H, Umemoto A, Yamauchi T, Itoh K (2006) Proteomic alteration in gastric adenocarcinomas from Japanese patients. Mol Cancer 25(5):75CrossRef
3.
Zurück zum Zitat Samadi F, Babaei M, Yazdanbod A, Fallah M, Nouraie M, Nasrollahzadeh D, Sadjadi A, Derakhshan MH, Shokuhi B, Fuladi R, Malekzadeh R (2007) Survival rate of gastric and esophageal cancers in Ardabil province, North-West of Iran. Arch Iran Med 10(1):32–37PubMed Samadi F, Babaei M, Yazdanbod A, Fallah M, Nouraie M, Nasrollahzadeh D, Sadjadi A, Derakhshan MH, Shokuhi B, Fuladi R, Malekzadeh R (2007) Survival rate of gastric and esophageal cancers in Ardabil province, North-West of Iran. Arch Iran Med 10(1):32–37PubMed
4.
Zurück zum Zitat Pilco P, Payet E, Caceres E (2006) Gastric cancer in Lima. Rev Gastroenterol Peru 26(4):377–385PubMed Pilco P, Payet E, Caceres E (2006) Gastric cancer in Lima. Rev Gastroenterol Peru 26(4):377–385PubMed
5.
Zurück zum Zitat Suwanrungruang K, Wiangnon S, Sriamporn S, Sookprasert A, Rangsrikajee D, Kamsa-Ard S, Horsith S, Usantia P (2006) Trends in incidences of stomach and colorectal cancer in Khon Kaen, Thailand 1985–2004. Asian Pac J Cancer Prev 7(4):623–626PubMed Suwanrungruang K, Wiangnon S, Sriamporn S, Sookprasert A, Rangsrikajee D, Kamsa-Ard S, Horsith S, Usantia P (2006) Trends in incidences of stomach and colorectal cancer in Khon Kaen, Thailand 1985–2004. Asian Pac J Cancer Prev 7(4):623–626PubMed
6.
Zurück zum Zitat Volate SR, Davenport DM, Muga SJ, Wargovich MJ (2005) Modulation of aberrant crypt foci and apoptosis by dietary herbal supplements (quercetin, curcumin, silymarin, ginseng and rutin). Carcinogenesis 26:1450–1456PubMedCrossRef Volate SR, Davenport DM, Muga SJ, Wargovich MJ (2005) Modulation of aberrant crypt foci and apoptosis by dietary herbal supplements (quercetin, curcumin, silymarin, ginseng and rutin). Carcinogenesis 26:1450–1456PubMedCrossRef
7.
Zurück zum Zitat De Stefani E, Correa P, Boffetta P, Ronco A, Brennan P, Deneo-Pellegrini H, Mendilaharsu M (2001) Plant foods and risk of gastric cancer: a case–control study in Uruguay. Eur J Cancer Prev 10:357–364PubMedCrossRef De Stefani E, Correa P, Boffetta P, Ronco A, Brennan P, Deneo-Pellegrini H, Mendilaharsu M (2001) Plant foods and risk of gastric cancer: a case–control study in Uruguay. Eur J Cancer Prev 10:357–364PubMedCrossRef
8.
Zurück zum Zitat Lynn A, Collins A, Fuller Z, Hillman K, Ratcliffe B (2006) Cruciferous vegetables and colo-rectal cancer. Proc Nutr Soc 65:135–144PubMedCrossRef Lynn A, Collins A, Fuller Z, Hillman K, Ratcliffe B (2006) Cruciferous vegetables and colo-rectal cancer. Proc Nutr Soc 65:135–144PubMedCrossRef
9.
Zurück zum Zitat Penner R, Fedorak RN, Madsen KL (2005) Probiotics and nutraceuticals: non-medicinal treatments of gastrointestinal diseases. Curr Opin Pharmacol 5:596–603PubMedCrossRef Penner R, Fedorak RN, Madsen KL (2005) Probiotics and nutraceuticals: non-medicinal treatments of gastrointestinal diseases. Curr Opin Pharmacol 5:596–603PubMedCrossRef
10.
Zurück zum Zitat Davis CD, Hord NG (2005) Nutritional “omics” technologies for elucidating the role(s) of bioactive food components in colon cancer prevention. J Nutr 135:2694–2697PubMed Davis CD, Hord NG (2005) Nutritional “omics” technologies for elucidating the role(s) of bioactive food components in colon cancer prevention. J Nutr 135:2694–2697PubMed
11.
Zurück zum Zitat Karcz W, Gluszek S, Kot M, Matykiewicz J (2006) Influence of nutritional treatment on the postoperative course in patients with gastric cancer. Adv Med Sci 51:278–282PubMed Karcz W, Gluszek S, Kot M, Matykiewicz J (2006) Influence of nutritional treatment on the postoperative course in patients with gastric cancer. Adv Med Sci 51:278–282PubMed
12.
Zurück zum Zitat Yasui W, Sentani K, Motoshita J, Nakayama H (2006) Molecular pathobiology of gastric cancer. Scand J Surg 95(4):225–231PubMed Yasui W, Sentani K, Motoshita J, Nakayama H (2006) Molecular pathobiology of gastric cancer. Scand J Surg 95(4):225–231PubMed
13.
Zurück zum Zitat Peng DF, Kanai Y, Sawada M (2005) Increased DNA methyltransferase 1 (DNMT1) protein expression in precancerous conditions and ductal carcinomas of the pancreas. Cancer Sci 96(7):403–408PubMedCrossRef Peng DF, Kanai Y, Sawada M (2005) Increased DNA methyltransferase 1 (DNMT1) protein expression in precancerous conditions and ductal carcinomas of the pancreas. Cancer Sci 96(7):403–408PubMedCrossRef
14.
Zurück zum Zitat Saito Y, Kanai Y, Nakagawa T (2003) Increased protein expression of DNA methyltransferase (DNMT) 1 is significantly correlated with the malignant potential and poor prognosis of human hepatocellular carcinomas. Int J Cancer 105(4):527–532PubMedCrossRef Saito Y, Kanai Y, Nakagawa T (2003) Increased protein expression of DNA methyltransferase (DNMT) 1 is significantly correlated with the malignant potential and poor prognosis of human hepatocellular carcinomas. Int J Cancer 105(4):527–532PubMedCrossRef
15.
Zurück zum Zitat Fang JY, Lu R, Mikovits JA, Cheng ZH, Zhu HY, Chen YX (2006) Regulation of hMSH2 and hMLH1 expression in the human colon cancer cell line SW1116 by DNA methyltransferase 1. Cancer Lett 233(1):124–130PubMedCrossRef Fang JY, Lu R, Mikovits JA, Cheng ZH, Zhu HY, Chen YX (2006) Regulation of hMSH2 and hMLH1 expression in the human colon cancer cell line SW1116 by DNA methyltransferase 1. Cancer Lett 233(1):124–130PubMedCrossRef
16.
Zurück zum Zitat Fang JY, Xiao SD (2001) Alteration of DNA methylation in gastrointestinal carcinogenesis. J Gastroenterol Hepatol 16(9):960–968PubMedCrossRef Fang JY, Xiao SD (2001) Alteration of DNA methylation in gastrointestinal carcinogenesis. J Gastroenterol Hepatol 16(9):960–968PubMedCrossRef
17.
Zurück zum Zitat Bheemanaik S, Reddy YV, Rao DN (2006) Structure, function and mechanism of exocyclic DNA methyltransferases. Biochem J 399(2):177–190PubMedCrossRef Bheemanaik S, Reddy YV, Rao DN (2006) Structure, function and mechanism of exocyclic DNA methyltransferases. Biochem J 399(2):177–190PubMedCrossRef
18.
Zurück zum Zitat Shen Y, Chow J, Wang Z, Fan G (2006) Abnormal CpG island methylation occurs during in vitro differentiation of human embryonic stem cells. Hum Mol Genet 15(17):2623–2635PubMedCrossRef Shen Y, Chow J, Wang Z, Fan G (2006) Abnormal CpG island methylation occurs during in vitro differentiation of human embryonic stem cells. Hum Mol Genet 15(17):2623–2635PubMedCrossRef
19.
Zurück zum Zitat Araujo FD, Croteau S, Slack AD (2001) The DNMT1 target recognition domain resides in the N terminus. J Biol Chem 276:6930–6936PubMedCrossRef Araujo FD, Croteau S, Slack AD (2001) The DNMT1 target recognition domain resides in the N terminus. J Biol Chem 276:6930–6936PubMedCrossRef
20.
Zurück zum Zitat Geiman TM, Sankpal UT, Robertson AK (2004) Isolation and characterization of a novel DNA methyltransferase complex linking DNMT3B with components of the mitotic chromosome condensation machinery. Nucleic Acids Res 32(9):2716–2729PubMedCrossRef Geiman TM, Sankpal UT, Robertson AK (2004) Isolation and characterization of a novel DNA methyltransferase complex linking DNMT3B with components of the mitotic chromosome condensation machinery. Nucleic Acids Res 32(9):2716–2729PubMedCrossRef
21.
Zurück zum Zitat Fang JY, Cheng ZH, Chen YX, Lu R, Yang L, Zhu HY, Lu LG (2004) Expression of DNMT1, demethylase, MeCP2 and methylation of tumor-related genes in human gastric cancer. World J Gastroenterol 10(23):3394–3398PubMed Fang JY, Cheng ZH, Chen YX, Lu R, Yang L, Zhu HY, Lu LG (2004) Expression of DNMT1, demethylase, MeCP2 and methylation of tumor-related genes in human gastric cancer. World J Gastroenterol 10(23):3394–3398PubMed
22.
Zurück zum Zitat Luczak MW, Jagodzinski PP (2006) The role of DNA methylation in cancer development. Folia Histochem Cytobiol 44(3):143–154PubMed Luczak MW, Jagodzinski PP (2006) The role of DNA methylation in cancer development. Folia Histochem Cytobiol 44(3):143–154PubMed
23.
Zurück zum Zitat Zhang LL, Wu JX (2006) DNA methylation: an epigenetic mechanism for tumorigenesis. Yi Chuan 28(7):880–885PubMed Zhang LL, Wu JX (2006) DNA methylation: an epigenetic mechanism for tumorigenesis. Yi Chuan 28(7):880–885PubMed
24.
Zurück zum Zitat Esteller M, Corn PG, Baylin SB, Herman JG (2001) A gene hypermethylation profile of human cancer. Cancer Res 61:3225–3229PubMed Esteller M, Corn PG, Baylin SB, Herman JG (2001) A gene hypermethylation profile of human cancer. Cancer Res 61:3225–3229PubMed
25.
Zurück zum Zitat Hermann A, Gowher H, Jeltsch A (2004) Biochemistry and biology of mammalian DNA methyltransferases. Cell Mol Life Sci 61:2571–2587PubMedCrossRef Hermann A, Gowher H, Jeltsch A (2004) Biochemistry and biology of mammalian DNA methyltransferases. Cell Mol Life Sci 61:2571–2587PubMedCrossRef
26.
Zurück zum Zitat Watanabe D, Uchiyama K, Hanaoka K (2006) Transition of mouse de novo methyltransferases expression from DNMT3b to DNMT3a during neural progenitor cell development. Neuroscience 142(3):727–737PubMedCrossRef Watanabe D, Uchiyama K, Hanaoka K (2006) Transition of mouse de novo methyltransferases expression from DNMT3b to DNMT3a during neural progenitor cell development. Neuroscience 142(3):727–737PubMedCrossRef
27.
Zurück zum Zitat Robertson KD, Keyomarsi K, Gonzales FA, Velicescu M, Jones PA (2000) Differential mRNA expression of the human DNA methyltransferases (DNMTs) 1, 3a and 3b during the G0/G1 to S phase transition in normal and tumor cells. Nucleic Acids Res 28(10):2108–2113PubMedCrossRef Robertson KD, Keyomarsi K, Gonzales FA, Velicescu M, Jones PA (2000) Differential mRNA expression of the human DNA methyltransferases (DNMTs) 1, 3a and 3b during the G0/G1 to S phase transition in normal and tumor cells. Nucleic Acids Res 28(10):2108–2113PubMedCrossRef
28.
Zurück zum Zitat Yamada Y, Jackson-Grusby L, Linhart H (2005) Opposing effects of DNA hypomethylation on intestinal and liver carcinogenesis. Proc Natl Acad Sci USA 102(38):13580–13585PubMedCrossRef Yamada Y, Jackson-Grusby L, Linhart H (2005) Opposing effects of DNA hypomethylation on intestinal and liver carcinogenesis. Proc Natl Acad Sci USA 102(38):13580–13585PubMedCrossRef
29.
Zurück zum Zitat Vallbohmer D, Brabender J, Yang D (2006) DNA methyltransferases messenger RNA expression and aberrant methylation of CpG islands in non-small-cell lung cancer: association and prognostic value. Clin Lung Cancer 8(1):39–44PubMedCrossRef Vallbohmer D, Brabender J, Yang D (2006) DNA methyltransferases messenger RNA expression and aberrant methylation of CpG islands in non-small-cell lung cancer: association and prognostic value. Clin Lung Cancer 8(1):39–44PubMedCrossRef
30.
Zurück zum Zitat Tian Z, Zhang ZY, Li L, Li J (2006) Expression of DNA methyltransferases in salivary adenoid cystic carcinoma and its association with the CpG islands methylation of tumor suppressor genes. Zhonghua Kou Qiang Yi Xue Za Zhi 41(7):411–415PubMed Tian Z, Zhang ZY, Li L, Li J (2006) Expression of DNA methyltransferases in salivary adenoid cystic carcinoma and its association with the CpG islands methylation of tumor suppressor genes. Zhonghua Kou Qiang Yi Xue Za Zhi 41(7):411–415PubMed
31.
Zurück zum Zitat Patra SK, Patra A, Zhao H, Dahiya R (2002) DNA methyltransferase and demethylase in human prostate cancer. Mol Carcinog 33(3):163–171PubMedCrossRef Patra SK, Patra A, Zhao H, Dahiya R (2002) DNA methyltransferase and demethylase in human prostate cancer. Mol Carcinog 33(3):163–171PubMedCrossRef
32.
Zurück zum Zitat Zhu Y-M, Huang Q, LinJ, Hu Y (2006) Expression of human DNA methyltransferase 1 in colorectal cancer tissues and their corresponding distant normal tissues. Int J Colorectal Dis 22:661–666PubMedCrossRef Zhu Y-M, Huang Q, LinJ, Hu Y (2006) Expression of human DNA methyltransferase 1 in colorectal cancer tissues and their corresponding distant normal tissues. Int J Colorectal Dis 22:661–666PubMedCrossRef
33.
Zurück zum Zitat Nakagawa T, Kanai Y, Saito Y, Kitamura T, Kakizoe T, Hirohashi S (2003) Increased DNA methyltransferase 1 protein expression in human transitional cell carcinoma of the bladder. J Urol 170:2463–2466PubMedCrossRef Nakagawa T, Kanai Y, Saito Y, Kitamura T, Kakizoe T, Hirohashi S (2003) Increased DNA methyltransferase 1 protein expression in human transitional cell carcinoma of the bladder. J Urol 170:2463–2466PubMedCrossRef
34.
Zurück zum Zitat Kanai Y, Ushijima S, Kondo Y, Nakanishi Y, Hirohashi S (2001) DNA methyltransferase expression and DNA methylation of CPG islands and peri-centromeric satellite regions in human colorectal and stomach cancers. Int J Cancer 91:205–212PubMedCrossRef Kanai Y, Ushijima S, Kondo Y, Nakanishi Y, Hirohashi S (2001) DNA methyltransferase expression and DNA methylation of CPG islands and peri-centromeric satellite regions in human colorectal and stomach cancers. Int J Cancer 91:205–212PubMedCrossRef
35.
Zurück zum Zitat Mizuno S, Chijiwa T, Okamura T, Akashi K, Fukumaki Y, Niho Y, Sasaki H (2001) Expression of DNA methyltransferases DNMT1, 3A, and 3B in normal hematopoiesis and in acute and chronic myelogenous leukemia. Blood 97:1172–1179PubMedCrossRef Mizuno S, Chijiwa T, Okamura T, Akashi K, Fukumaki Y, Niho Y, Sasaki H (2001) Expression of DNA methyltransferases DNMT1, 3A, and 3B in normal hematopoiesis and in acute and chronic myelogenous leukemia. Blood 97:1172–1179PubMedCrossRef
36.
Zurück zum Zitat Saito Y, Kanai Y, Sakamoto M, Saito H, Ishii H, Hirohashi S (2001) Expression of mRNA for DNA methyltransferases and methyl-CpG-binding proteins and DNA methylation status on CpG islands and pericentromeric satellite regions during human hepatocarcinogenesis. Hepatology 33:561–568PubMedCrossRef Saito Y, Kanai Y, Sakamoto M, Saito H, Ishii H, Hirohashi S (2001) Expression of mRNA for DNA methyltransferases and methyl-CpG-binding proteins and DNA methylation status on CpG islands and pericentromeric satellite regions during human hepatocarcinogenesis. Hepatology 33:561–568PubMedCrossRef
37.
Zurück zum Zitat Sato M, Horio Y, Sekido Y, Minna JD, Shimokata K, Hasegawa Y (2002) The expression of DNA methyltransferases and methyl-CpG-binding proteins is not associated with the methylation status of p14(ARF), p16(INK4a) and RASSF1A in human lung cancer cell lines. Oncogene 21:4822–4829PubMedCrossRef Sato M, Horio Y, Sekido Y, Minna JD, Shimokata K, Hasegawa Y (2002) The expression of DNA methyltransferases and methyl-CpG-binding proteins is not associated with the methylation status of p14(ARF), p16(INK4a) and RASSF1A in human lung cancer cell lines. Oncogene 21:4822–4829PubMedCrossRef
38.
Zurück zum Zitat Lin RK, Hsu HS, Chang JW (2007) Alteration of DNA methyltransferases contributes to 5′CpG methylation and poor prognosis in lung cancer. Lung Cancer 55(2):205–213PubMedCrossRef Lin RK, Hsu HS, Chang JW (2007) Alteration of DNA methyltransferases contributes to 5′CpG methylation and poor prognosis in lung cancer. Lung Cancer 55(2):205–213PubMedCrossRef
39.
Zurück zum Zitat Girault I, Tozlu S, Lidereau R, Bièche I (2003) Expression analysis of DNA methyltransferases 1, 3A, and 3B in sporadic breast carcinomas. Clin Cancer Res 9:4415–4422PubMed Girault I, Tozlu S, Lidereau R, Bièche I (2003) Expression analysis of DNA methyltransferases 1, 3A, and 3B in sporadic breast carcinomas. Clin Cancer Res 9:4415–4422PubMed
40.
Zurück zum Zitat Etoh T, Kanai Y, Ushijima S, Nakagawa T, Nakanishi Y, Sasako M (2005) Increased DNA methyltransferase 1 (DNMT1) protein expression correlates significantly with poorer tumor differentiation and frequent DNA hypermethylation of multiple CpG islands in gastric cancers. Am J Pathol 164:689–699 Etoh T, Kanai Y, Ushijima S, Nakagawa T, Nakanishi Y, Sasako M (2005) Increased DNA methyltransferase 1 (DNMT1) protein expression correlates significantly with poorer tumor differentiation and frequent DNA hypermethylation of multiple CpG islands in gastric cancers. Am J Pathol 164:689–699
Metadaten
Titel
The Expression and Clinical Significance of DNA Methyltransferase Proteins in Human Gastric Cancer
verfasst von
Wen-Jin Ding
Jing-Yuan Fang
Xiao-Yu Chen
Yan-Shen Peng
Publikationsdatum
01.08.2008
Verlag
Springer US
Erschienen in
Digestive Diseases and Sciences / Ausgabe 8/2008
Print ISSN: 0163-2116
Elektronische ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-007-0145-2

Weitere Artikel der Ausgabe 8/2008

Digestive Diseases and Sciences 8/2008 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.